Premium
Letter: optimising response to ustekinumab therapy for patients with Crohn’s disease
Author(s) -
Hudson Joshua,
Herfarth Hans H.,
Barnes Edward L.
Publication year - 2020
Publication title -
alimentary pharmacology and therapeutics
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 3.308
H-Index - 177
eISSN - 1365-2036
pISSN - 0269-2813
DOI - 10.1111/apt.15961
Subject(s) - ustekinumab , medicine , crohn's disease , crohn disease , medline , disease , adalimumab , political science , law
LINKED CONTENT This article is linked to Kopylov et al and Kopylov papers. To view these articles, visit https://doi.org/10.1111/apt.15784 and https://doi.org/10.1111/apt.15974